179 related articles for article (PubMed ID: 7921210)
1. Bone resorption in healthy and osteoporotic postmenopausal women: comparison markers for serum carboxy-terminal telopeptide of type I collagen and urinary pyridinium cross-links.
Välimäki MJ; Tähtelä R; Jones JD; Peterson JM; Riggs BL
Eur J Endocrinol; 1994 Sep; 131(3):258-62. PubMed ID: 7921210
[TBL] [Abstract][Full Text] [Related]
2. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.
Garnero P; Shih WJ; Gineyts E; Karpf DB; Delmas PD
J Clin Endocrinol Metab; 1994 Dec; 79(6):1693-700. PubMed ID: 7989477
[TBL] [Abstract][Full Text] [Related]
3. New biochemical markers of bone resorption derived from collagen breakdown in the study of postmenopausal osteoporosis.
Guerrero R; Diaz Martin MA; Diaz Diego EM; Disla T; Rapado A; de la Piedra C
Osteoporos Int; 1996; 6(4):297-302. PubMed ID: 8883118
[TBL] [Abstract][Full Text] [Related]
4. [Studies of type I collagen related substances as bone metastatic markers of prostate carcinoma with special regard to serum carboxyterminal propeptide of type. I. Procollagen (PICP), cross-linked carboxyterminal telopeptide of type I collagen (ICTP) and Urinary deoxypyridinoline levels].
Imai T; Honda M; Maeda S; Hosoya Y; Arai T; Sumi S; Umeda H; Yano M; Koga F; Arai K; Yoshida K
Nihon Hinyokika Gakkai Zasshi; 1998 Apr; 89(4):484-91. PubMed ID: 9597867
[TBL] [Abstract][Full Text] [Related]
5. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
[TBL] [Abstract][Full Text] [Related]
6. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
Katagiri M; Fukunaga M; Ohtawa T; Harada T
World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of bone disease in multiple myeloma: a comparison between the resorption markers urinary deoxypyridinoline/creatinine (DPD) and serum ICTP, and an evaluation of the DPD/osteocalcin and ICTP/osteocalcin ratios.
Carlson K; Larsson A; Simonsson B; Turesson I; Westin J; Ljunghall S
Eur J Haematol; 1999 May; 62(5):300-6. PubMed ID: 10359057
[TBL] [Abstract][Full Text] [Related]
8. Nocturnal rise in markers of bone resorption is not abolished by bedtime calcium or calcitonin.
Sairanen S; Tähtelä R; Laitinen K; Karonen SL; Välimäki MJ
Calcif Tissue Int; 1994 Nov; 55(5):349-52. PubMed ID: 7866915
[TBL] [Abstract][Full Text] [Related]
9. Change of cross-linked telopeptide of type I collagen (ICTP) and other bone resorption markers in patients with bone fragility fractures.
Takahara K; Kamimura M; Hashidate H; Uchiyama S; Nakagawa H
J Orthop Sci; 2007 May; 12(3):219-26. PubMed ID: 17530373
[TBL] [Abstract][Full Text] [Related]
10. The carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen in serum as a marker of bone resorption: the effect of nandrolone decanoate and hormone replacement therapy.
Hassager C; Jensen LT; Pødenphant J; Thomsen K; Christiansen C
Calcif Tissue Int; 1994 Jan; 54(1):30-3. PubMed ID: 8118750
[TBL] [Abstract][Full Text] [Related]
11. Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients.
Kushida K; Takahashi M; Kawana K; Inoue T
J Clin Endocrinol Metab; 1995 Aug; 80(8):2447-50. PubMed ID: 7629240
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of biochemical markers in patients with metabolic bone disorders.
Hoshino H; Kushida K; Takahashi M; Kawana K; Denda M; Yamazaki K; Inoue T
Endocr Res; 1998 Feb; 24(1):55-64. PubMed ID: 9553754
[TBL] [Abstract][Full Text] [Related]
13. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
[TBL] [Abstract][Full Text] [Related]
14. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
Alvarez L; Guañabens N; Peris P; Monegal A; Bedini JL; Deulofeu R; Martinez de Osaba MJ; Muñoz-Gomez J; Rivera-Fillat F; Ballesta AM
J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468
[TBL] [Abstract][Full Text] [Related]
15. Bone resorption parameters [carboxy-terminal telopeptide of type-I collagen (ICTP), amino-terminal collagen type-I telopeptide (NTx), and deoxypyridinoline (Dpd)] in MGUS and multiple myeloma.
Jakob C; Zavrski I; Heider U; Brux B; Eucker J; Langelotz C; Sinha P; Possinger K; Sezer O
Eur J Haematol; 2002 Jul; 69(1):37-42. PubMed ID: 12270060
[TBL] [Abstract][Full Text] [Related]
16. Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy.
Peris P; Alvarez L; Monegal A; Guañabens N; Durán M; Pons F; Martínez de Osaba MJ; Echevarría M; Ballesta AM; Muñoz-Gómez J
Bone; 1999 Sep; 25(3):349-53. PubMed ID: 10495139
[TBL] [Abstract][Full Text] [Related]
17. Biochemical markers of bone turnover in breast cancer patients with bone metastases: a preliminary report.
Shimozuma K; Sonoo H; Fukunaga M; Ichihara K; Aoyama T; Tanaka K
Jpn J Clin Oncol; 1999 Jan; 29(1):16-22. PubMed ID: 10073146
[TBL] [Abstract][Full Text] [Related]
18. Effect of the menopause and hormone replacement therapy on the carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen.
Hassager C; Risteli J; Risteli L; Christiansen C
Osteoporos Int; 1994 Nov; 4(6):349-52. PubMed ID: 7696831
[TBL] [Abstract][Full Text] [Related]
19. Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline.
Okabe R; Inaba M; Nakatsuka K; Miki T; Naka H; Moriguchi A; Nishizawa Y
J Bone Miner Metab; 2004; 22(2):127-31. PubMed ID: 14999523
[TBL] [Abstract][Full Text] [Related]
20. Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma.
Abildgaard N; Glerup H; Rungby J; Bendix-Hansen K; Kassem M; Brixen K; Heickendorff L; Nielsen JL; Eriksen EF
Eur J Haematol; 2000 Feb; 64(2):121-9. PubMed ID: 10997332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
